The global cold plasma market was valued at approximately USD 128.9 million in 2023 and is anticipated to grow significantly, reaching an estimated USD 358.1 million by 2030. This projected growth reflects a robust compound annual growth rate (CAGR) of 15.8% from 2024 to 2030. The primary factor driving this market expansion is the ongoing advancement within the healthcare industry, which has created a rising demand for sophisticated technologies aimed at improving patient outcomes. Healthcare providers are increasingly adopting non-invasive and safer treatment methods, and cold plasma technology fits these needs well, as it enhances treatment effectiveness while minimizing patient discomfort.

Cold plasma, also referred to as non-equilibrium plasma, is a unique form of ionized gas in which the various components (such as electrons and ions) exist at distinctly different temperatures. It is generated by energizing gases to produce a mix of reactive species. These species are highly effective in a range of applications, particularly in the medical field, due to their antimicrobial, anti-inflammatory, and healing-promoting properties. Unlike traditional thermal plasmas, cold plasma operates at low temperatures, making it suitable for contact with sensitive biological tissues without causing thermal damage.

The application of cold plasma technology has expanded rapidly, with notable uses in cancer treatment, sterilization processes, and wound healing. These benefits have significantly fueled its adoption in modern healthcare practices. In cancer therapy, cold plasma offers the potential to target and destroy cancer cells selectively, minimizing damage to surrounding healthy tissue. Its sterilization capability makes it invaluable in hospitals and clinics, particularly for disinfecting surgical instruments and surfaces without the use of heat or harsh chemicals.

Key Market Trends & Insights:

  • From a regional standpoint, North America led the global cold plasma market in 2023, capturing the largest revenue share of 41.3%. Within North America, the United States emerged as the dominant contributor, accounting for a substantial 81.4% share of the regional market. The U.S.'s leadership is attributed to its advanced healthcare infrastructure, significant investment in medical R&D, and early adoption of emerging technologies like cold plasma.
  • Looking ahead, the Asia Pacific region is projected to experience the fastest market growth, with an expected CAGR of 16.8% over the forecast period. This rapid expansion is driven by increased healthcare spending, growing awareness of innovative medical treatments, and rising prevalence of chronic diseases across countries such as China, India, and Japan.
  • When analyzed by pressure type, the atmospheric pressure segment was the leading contributor in 2023, holding the largest revenue share of 65.5%. Meanwhile, the low-pressure cold plasma segment is also poised for strong growth, with a projected CAGR of 15.6% during the forecast period, fueled by ongoing research and increasing use in delicate medical applications.
  • In terms of application areas, the wound healing segment emerged as the most dominant in 2023, accounting for the highest revenue share of 31.0%. The cancer treatment application, on the other hand, is projected to witness the fastest growth at a CAGR of 17% over the coming years.

Order a free sample PDF of the Cold Plasma Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

  • 2023 Market Size: USD 128.9 Million
  • 2030 Projected Market Size: USD 358.1 Million
  • CAGR (2024 - 2030): 15.8%
  • North America: Largest market in 2023

Key Players

The following are the leading companies in the cold plasma market. These companies collectively hold the largest market share and dictate industry trends.

  • Bovie Medical Corporation
  • Neoplas Med GmbH
  • Europlasma NV
  • P2i Ltd.
  • US Medical Innovations;
  • Apyx Medical.
  • Adtec Healthcare Limited.
  • terraplasma medical GmbH
  • CINOGY System GmbH

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

In conclusion, the global cold plasma market is poised for substantial growth, driven by advancements in healthcare technology, rising demand for non-invasive treatments, and expanding applications in areas such as wound healing, sterilization, and cancer therapy. The strong market performance in North America and rapid growth in the Asia Pacific region reflect increasing global adoption. With ongoing research and proven effectiveness in eliminating airborne pathogens, cold plasma is emerging as a transformative solution across medical and industrial domains, paving the way for continued innovation and market expansion through 2030.